Distribution, activation and tryptase/chymase phenotype of mast cells in the rheumatoid lesion.
about
Analysis of the cell infiltrate and expression of proinflammatory cytokines and matrix metalloproteinases in arthroscopic synovial biopsies: comparison with synovial samples from patients with end stage, destructive rheumatoid arthritisMast cell activation and its relation to proinflammatory cytokine production in the rheumatoid lesionHigh CXCR3 expression in synovial mast cells associated with CXCL9 and CXCL10 expression in inflammatory synovial tissues of patients with rheumatoid arthritisMast cells in inflammatory arthritisAnalysis of the cell infiltrate and expression of matrix metalloproteinases and granzyme B in paired synovial biopsy specimens from the cartilage-pannus junction in patients with RAMast cells, cytokines, and metalloproteinases at the rheumatoid lesion: dual immunolocalisation studies.Butrin, isobutrin, and butein from medicinal plant Butea monosperma selectively inhibit nuclear factor-kappaB in activated human mast cells: suppression of tumor necrosis factor-alpha, interleukin (IL)-6, and IL-8The pathogenesis and prevention of joint damage in rheumatoid arthritis: advances from synovial biopsy and tissue analysis.A novel FcεRIβ-chain truncation regulates human mast cell proliferation and survivalPotent selective nonpeptidic inhibitors of human lung tryptase.Synovial mast cell responses during clinical improvement in early rheumatoid arthritis.Demonstration of mast cell chemotactic activity in synovial fluid from rheumatoid patientsMetaplastic transformation of urinary bladder epithelium: effect on mast cell recruitment, distribution, and phenotype expression.Targeting Syk as a treatment for allergic and autoimmune disorders.The histamine H4 receptor in autoimmune disease.IL-33 exacerbates antigen-induced arthritis by activating mast cells.Mast cell depletion in the preclinical phase of collagen-induced arthritis reduces clinical outcome by lowering the inflammatory cytokine profile.Mast cells contribute to autoimmune inflammatory arthritis via their tryptase/heparin complexes.Mast cell-restricted, tetramer-forming tryptases induce aggrecanolysis in articular cartilage by activating matrix metalloproteinase-3 and -13 zymogensDegenerative Joint Diseases and Neuroinflammation.Polyphenol-rich pomegranate fruit extract (POMx) suppresses PMACI-induced expression of pro-inflammatory cytokines by inhibiting the activation of MAP Kinases and NF-kappaB in human KU812 cells.Inhibitory effect of inflammatory cytokines production from activated mast cells by Gamisopoonghwanghyul-tang.Mast cells in the rheumatoid lesion--ringleaders or innocent bystanders?Tumor necrosis factor alpha promotes the expression of stem cell factor in synovial fibroblasts and their capacity to induce mast cell chemotaxis.Functional KCa3.1 K+ channels are required for human lung mast cell migrationEosinophils are an insignificant cellular component of rheumatoid synovium in patients with late stage disease: comparative distributions with mast cells and macrophages.Inhibition of c-kit tyrosine kinase by imatinib mesylate induces apoptosis in mast cells in rheumatoid synovia: a potential approach to the treatment of arthritis.Effects of induced mast cell activation on prostaglandin E and metalloproteinase production by rheumatoid synovial tissue in vitro.Human mast cell subtypes in conjunctiva of patients with atopic keratoconjunctivitis, ocular cicatricial pemphigoid and Stevens-Johnson syndrome.
P2860
Q24674100-7535D25F-1055-40A8-8159-B0B5D545749CQ24792173-5016280A-0820-48D4-8654-5D0F2E3F4759Q24797400-D12FD494-3310-4FA2-B53B-32F9C768EBA5Q24798636-71AC56D8-BC0B-4472-A340-895C76CEE673Q28364842-54B4DBD4-3EBD-4A0F-8236-66AE432D6D9DQ33578511-AB5A38C6-2430-4147-971E-B49FF677592BQ33861973-D7E5D66E-8837-4219-AC72-C9FE423AAE78Q34122715-0B894781-5D02-4808-89C4-D93EE27CD7CDQ34378845-56E641A4-F790-47EB-87FB-E6CB48C658C6Q35546388-6BE573E2-3C95-467C-B1B4-016D7D186DB6Q35547604-A4622858-583D-416F-8849-7203C72DBC24Q35550183-D1E40E1F-F926-4777-9809-3DE63DC97411Q35753134-873C98FE-04C2-4389-A808-C47FF8D3FBD9Q35814437-3AD89A88-4757-48D7-872B-54E138F7695AQ36623087-F5990934-D190-41B5-B6DE-AB93AEAED207Q36800502-D843236F-73A2-4FCE-A1D5-58639F879F21Q37001999-3991AF56-9837-4FE9-9E2B-EA647E04FE2EQ37029408-3879A39F-728C-48CC-96E4-C0B72A8B4FD9Q37055039-90DEBA15-8A61-46D9-8946-73AA4229CD85Q39063573-9599FEB1-1B5D-4DA2-8C76-15475750D0E8Q39897321-42D4F266-D4FF-4129-801D-F71B3F55A8ABQ40469285-DA4CBFC0-32FA-4E01-925B-F7EA11797AE4Q40478771-5C54A10E-B421-4BF9-8409-BD12E4C9B59EQ40904867-CE7CAC95-072D-418F-AD15-5622B39DF61CQ40985571-80C8F99A-892E-4318-8927-90088E83E773Q41476009-0B347AC9-8472-46DE-923B-312142A31866Q43048581-5A2A7F22-7E46-4EA9-B6E5-0D6FA98574BFQ43053583-A1EBDFA8-E1EA-408C-8E54-8F563605DEEEQ44623460-A8E48289-5EEB-4EE1-AE83-80F3282BF769
P2860
Distribution, activation and tryptase/chymase phenotype of mast cells in the rheumatoid lesion.
description
1995 nî lūn-bûn
@nan
1995 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Distribution, activation and t ...... ells in the rheumatoid lesion.
@ast
Distribution, activation and t ...... ells in the rheumatoid lesion.
@en
Distribution, activation and t ...... ells in the rheumatoid lesion.
@nl
type
label
Distribution, activation and t ...... ells in the rheumatoid lesion.
@ast
Distribution, activation and t ...... ells in the rheumatoid lesion.
@en
Distribution, activation and t ...... ells in the rheumatoid lesion.
@nl
prefLabel
Distribution, activation and t ...... ells in the rheumatoid lesion.
@ast
Distribution, activation and t ...... ells in the rheumatoid lesion.
@en
Distribution, activation and t ...... ells in the rheumatoid lesion.
@nl
P2860
P356
P1476
Distribution, activation and t ...... ells in the rheumatoid lesion.
@en
P2093
P2860
P304
P356
10.1136/ARD.54.7.549
P407
P577
1995-07-01T00:00:00Z